GSK sells thrombosis brands to Aspen for $1.1 bn

Singapore: GlaxoSmithKline (GSK) has agreed to sell its thrombosis brands, Arixtra and Fraxiparine, and Notre-Dame de Bo...

October 1, 2013 | Tuesday | News
Why are bio firms in a hurry to set up shop in Malaysia?

India-based Agila Biotech, which is a subsidiary of Strides Arcolab, entered into a $34.4 million (RM107 million) build-...

April 17, 2013 | Wednesday | Analysis
India's Arunachal Pradesh to get Digital Healthcare Centers

Singapore: India's northeastern state of Arunachal Pradesh is wooing Samsung Electronics to set up units in the state. T...

July 27, 2016 | Wednesday | News
Mylan holds back $250 mn in Agila buyout

Singapore: With the US drug regulator, Food and Drug Administration (FDA) issuing a warning letter to one of Agila's Spe...

December 6, 2013 | Friday | News
Biobanking has attractive prospects in Asia

Asia is becoming increasingly important as a market for upcoming biobanks. Within Asia, India, China and Japan have attr...

June 12, 2012 | Tuesday | Opinion
China Cord Blood, Cordlife join hands for stem cell therapy services

Singapore: China Cord Blood Corporation (CCBC) and Cordlife Group, a multi-product healthcare company catering to the mo...

July 25, 2014 | Friday | News
Johns Hopkins releases NCD policy briefs

Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...

February 5, 2013 | Tuesday | Analysis
Lupin appoints Theresa Stevens as chief corporate development officer

Singapore: Pharma major Lupin announced the appointment of Theresa Stevens as Chief Corporate Development Officer for it...

April 24, 2014 | Thursday | News
Type 2 diabetes could be next epidemic in India, China

Singapore: Despite modern science's best efforts, the most common type of diabetes, Type 2, is reaching epidemic levels ...

February 7, 2013 | Thursday | Analysis
Challenge No 1: A culture cauldron

The countries in Asia have different languages, cultures and religion. Some of them are even a melting pot of people fro...

May 17, 2012 | Thursday | Analysis
Biocon registers 16 percent growth

Bangalore: India's leading biotech conglomerate Biocon records 16% revenue growth in FY14. The companies revenues for th...

April 25, 2014 | Friday | News
Suven gets patents for NCE in Canada, China and India

Bangalore: Suven Life Sciences received three product patents one each from Canada (2600271), China (CN 101544592B) and ...

February 4, 2014 | Tuesday | News
India approves STAAR Surgical's Visian ICL

New Delhi: US-based STAAR Surgical, a leading developer, manufacturer and marketer of implantable lenses and delivery sy...

August 20, 2013 | Tuesday | News
India's potential lures pharma MNCs

Singapore: There has been a stark increase in the number of consolidations and in-licensing agreements between multinati...

January 31, 2013 | Thursday | News
Exclusive: We can help shape Indian health services: NHS

Singapore: In June 2016, National Health Service's (NHS) Chairman Sir Malcolm Grant was in India and led a world-class d...

July 25, 2016 | Monday | Influencers
UK drugs regulator to halt approvals for clinical trials firm Quest Life Sciences

Singapore: The UK's healthcare regulator has decided to suspended marketing approval for a widely used antibiotic that h...

July 22, 2016 | Friday | News
Indian firm announces breakthrough for Zika vaccine

Singapore: Hyderabad, India based Vaccines and Bio-Therapeutic manufacturer, Bharat Biotech, announced breakthrough in d...

February 5, 2016 | Friday | News
Breast cancer market will rise to $3.4 billion by 2021'

Singapore: The Asia-Pacific (APAC) breast cancer market is set to experience considerable expansion from $1.9 billion in...

February 16, 2016 | Tuesday | News